Expert Advisory Group on Marketing of Opioids
The Expert Advisory Group on Marketing of Opioids was established to provide Health Canada with input and advice regarding the evidence on the extent, impact, and value of the pharmaceutical industry's marketing and advertising of opioids.
For more detailed information about the role of the Expert Advisory Group, please refer to the Terms of Reference.
Members of the Expert Advisory Group include, but are not limited to, health professionals, researchers/academia, and regulatory experts with expertise in areas such as pharmaceutical marketing and promotion, opioids, and prescribing behaviour.
The Expert Advisory Group includes four members, ensuring the appropriate representation of expertise and experience, as well as ability to provide focused advice. For more information on Expert Advisory Group members, please refer to:
Report a problem or mistake on this page
- Date modified: